This document discusses guidelines for biomedical waste management according to the BMW rules of 1998, 2011, and 2016 in India. It defines biomedical waste and outlines the objectives of proper waste management. It describes the classification of waste into categories based on risk level and provides guidelines for segregation, treatment, and disposal of each waste category according to the color-coding system. The risks of improper waste management to health and the environment are also discussed.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
2. OBJECTIVES
Various BMW rules (1998, 2011, 2016)
Classification of biomedical waste (various
waste categories)
Segregation of waste (colour coding system
for waste disposal)
Pre treatment & decontamination
Final disposal
2
3. INTRODUCTION OF WASTE MANAGEMENT
Hospital waste is a potential reservoir of
pathogenic micro-organisms.
Decontamination of waste and their ultimate
disposal are closely interrelated.
Laboratory wastes are of different category.
3
4. DEFINITION
“Bio-medical waste" means
any waste, which is generated during the
diagnosis, treatment or immunization of
human beings or animals or research
activities pertaining thereto or in the
production or testing of biological or in health
camps, including the categories mentioned in
Schedule-I appended to these rules;
4
5. APPLICATION
These rules shall apply to all persons who generate,
collect, receive, store, transport, treat, dispose, or handle
bio medical waste in any form including
Hospitals, nursing homes, clinics,
Dispensaries, veterinary institutions, animal houses, slaughter
house
Pathological laboratories, blood banks,
Ayush hospitals, clinical establishments,
Research or educational institutions,
Health camps, medical or surgical camps, vaccination camps,
blood donation camps,
First aid rooms of schools,
Forensic laboratories and research labs.
Mortuaries/autopsy centers
5
6. THESE RULES SHALL NOT APPLY TO
(a) radioactive wastes as covered under the provisions of the Atomic Energy
Act, 1962(33 of 1962) and the rules made there under;
(b) hazardous chemicals covered under the Manufacture, Storage and
Import of Hazardous Chemicals Rules, 1989 made under the Act;
(c) solid wastes covered under the Municipal Solid Waste (Management and
Handling) Rules, 2000 made under the Act;
(d) the lead acid batteries covered under the Batteries (Management and
Handling) Rules, 2001 made under the Act;
(e) hazardous wastes covered under the Hazardous Wastes (Management,
Handling and Transboundary Movement) Rules, 2008 made under the Act;
(f) waste covered under the e-Waste (Management and Handling) Rules, 2011
made under the Act; and
(g) hazardous micro organisms, genetically engineered micro
organisms and cells covered under the Manufacture, Use, Import, Export and
Storage of Hazardous Microorganisms, Genetically Engineered Micro organisms
or Cells Rules, 1989 made under the Act.
6
7. PEOPLE AT RISK
Doctors, Nurses & hospital staff
Patients & visitors of hospital
Veterinary staff
Health workers
Laboratory staff
Research staff
Slaughter house persons
Servants handling BMW
Disposal facility staff
Animal handling persons
7
8. HEALTH HAZARDS ASSOCIATED WITH
POOR MANAGEMENT OF BMW
Injury from sharps
Hospital acquired infections
Risk of infection outside the hospital for waste
handlers/scavengers & eventually general public
Occupational risk associated with hazardous
chemicals, drugs etc.
Unauthorized repackaging & sale of disposable
items & unused/expired drugs
8
9. ENVIRONMENT CONCERN
Spread of infection and disease through vectors (fly,
mosquito, insects etc.) which affect the in -house as well
as surrounding population.
Spread of infection through contact/injury among
medical/non-medical personnel and sweepers/rag
pickers, especially from the sharps (needles, blades etc.).
Spread of infection through unauthorised recycling of
disposable items such as hypodermic needles, tubes,
blades, bottles etc.
Reaction due to use of discarded medicines.
Toxic emissions from defective/inefficient incinerators.
Indiscriminate disposal of incinerator ash / residues
9
11. PROBLEMS RELATING TO BIOMEDICAL WASTE
The implementation of Bio-Waste regulation is
unsatisfactory as some hospitals are disposing of waste
in a haphazard, improper and indiscriminate manner.
Lack of motivation for proper BMW management.
Lack of segregation practices, results in mixing of hospital
wastes with general waste making the whole waste
stream hazardous.
Inappropriate segregation ultimately results in an incorrect
method of waste disposal.
Inadequate Bio-Medical waste management -------
environmental pollution, unpleasant smell, growth and
multiplication of vectors like insects, rodents and worms.
11
12. BENEFITS OF BIOMEDICAL WASTE MANAGEMENT
Cleaner and healthier surroundings.
Reduction in the incidence of hospital acquired and
general infections.
Reduction in the cost of infection control within the
hospital.
Reduction in the possibility of disease and death due to
reuse and repackaging of infectious disposables.
Low incidence of community and occupational health
hazards.
Reduction in the cost of waste management and
generation of revenue through appropriate treatment and
disposal of waste.
Improved image of the healthcare establishment and
increase the quality of life.
12
14. GENERATION OF WASTE
Types Site of Generation Disposal by
Non hazardous
(general waste 85%)
Office, kitchen, cafeteria billing, cashier,
rooms, hostels, residential area, rest
room, pantries in Wards, stores.
In black / green bag-
Municipal waste
Hazardous
(infectious & toxic 15%):-
-Hazardous but not
infectious- 5%
-Hazardous and
infectious- 10%
Wards, treatment room, nursing station,
isolation room, operation theaters,
intensive care unis & recovery room,
labour room & clinics, dental suites, minor
OT, blood bank, pharmacy & medical
stores, laboratories, animal house,
experimental centers, OPD treatment
room, injection & procedures rooms
As per biomedical
waste management
Rule 2016.
14
15. As per WHO, the biomedical wastes could be classified
into eight categories on the basis of the type of waste
and the risk of transmission of infectious material in
them.
1. General waste (domestic)
2. Pathological
3. Radioactive
4. Chemical
5. Infectious
6. Pharmaceutical wastes
7. Sharps and
8. Pressurized containers
15
16. NOTIFICATION & AMENDANTMENT
On 20th July 1998, Ministry of Environment &
forests, Govt. of India, formed a rule known
as Biomedical waste management and
handling rule 1998.
1st amendment dated on 06/03/2000
2nd amendment dated on 17/09/2003
BMW 2011 rule
BMW 2016 rule
16
17. CLASSIFICATION OF WASTE
To streamline over all handling of hospital waste, it has
been classified into several categories.
Each laboratory should have a working estimate of non-
hazardous and hazardous waste produced there on day-
to-day basis.
The waste segregation with an ultimate aim of safe
handling and disposal has been classified into various
categories.
They have been given colour coding for collection i.e. in a
specified container only a specified type of waste should
be collected.
Segregation at the point of generation of waste must be in
accordance with this colour coding.
Categories waste segregation and collection is a
mandatory legal requirement.
17
18. BMW RULES, 1998
Category no. Waste category Disposal
1 Human Anatomical Waste Incineration@@
2 Animal waste Incineration@@
3
Microbiology & Biotechnology
waste and other laboratory
waste
Disinfection at source by chemical treatment@ or by autoclaving/microwaving followed
by mutilation/shredding## and after treatment final disposal in secured landfill or disposal of recyclable
wastes (plastic or glass) through registered or authorized recyclers
4 Waste sharps
Disinfection by chemical treatment@ or destructionby needle and tip cutters, autoclaving or
microwaving followed by mutilation or shredding##, whichever is applicable and final disposal through authorized
CBWTF or disposal in secured landfill or designated concrete waste sharp pit
5
Discarded medicines and
cytotoxic drugs
Secure landfill or incineration@@
6 Soiled waste Incineration@@
7 Infectious solid waste
Disinfection by chemical treatment@ or autoclaving or microwaving
followed by mutilation or shredding## and after treatment final disposal through
registered or authorized recyclers
8 Liquid waste Chemical treatment@ and discharge into drains
9 Incineration Ash disposal in municipal landfill
10 Chemical waste
Chemical treatment@ and discharge into drains meeting the norms notified
under these rules and solid disposal in secured landfill
18
20. CONT…
There is lots of confusion about category &
color coding, few categories can be
discarded in more than 1 bag, no special
description of waste etc.
The table in next slides comes as product of
schedule I of Rule 4 and 7 of Bio-medical
waste (Management and handling) Rules
2011.
20
21. CONT…
Category
no.
Waste category Disposal
1
Human Anatomical Waste
(human tissues, organs, body parts)
Incineration@@
2
Animal waste
(animal tissue, organs, body parts, carcasses,
bleeding parts, fluid, blood and experimental
animals used in research, waste generated by
veterinary hospitals/ colleges, discharge from
hospitals, animal house)
Incineration@@
21
22. Category
no.
Waste category Disposal
3
Microbiology & Biotechnology waste
and other laboratory waste
(wastes from clinical samples, pathology,
biochemistry, haematology, blood bank,
laboratory cultures, stock or specimen of
microorganisms, live or attenuated
vaccines, human and animal cell culture
used in research and infectious agents
from research and industrial laboratories,
waste from production of biological
toxins, dishes and devices used for
transfer of cultures)
Disinfection at source by
chemical treatment@ or by
autoclaving/microwaving
followed by
mutilation/shredding## and
after treatment final disposal
in secured landfill or disposal
of recyclable wastes (plastic
or glass) through registered
or authorized recyclers
22
23. CONT…
Category
no.
Waste category Disposal
4
Waste sharps
(needles, glass syringes or syringes with
fixed needles, scalpels, blades, glass etc.
that may cause puncture and cuts. This
includes both used and unused sharps)
Disinfection by chemical treatment@
or destruction by needle and tip
cutters, autoclaving or microwaving
followed by mutilation or shredding##,
whichever is applicable and final
disposal through authorized CBWTF
or disposal in secured landfill or
designated concrete waste sharp pit
5
Discarded medicines and cytotoxic
drugs
(wastes comprising of outdated,
contaminated and discarded medicines)
Disposal in secure landfill or
incineration@@
23
24. CONT…
Category
no.
Waste category Disposal
6
Soiled waste
(Items contaminated with blood, and body
fluids including cotton, dressings, soiled
plaster casts, linen, beddings, other material
contaminated with blood)
Incineration@@
7
Infectious solid waste
(Wastes generated from disposable items
other than the waste sharps such as tubings,
hand gloves, saline bottles with IV tubes,
catheters, glass, intravenous sets etc.)
Disinfection by chemical
treatment@ or autoclaving or
microwaving followed by
mutilation or shredding## and after
treatment final disposal through
registered or authorized recyclers
24
25. CONT…
Category
no.
Waste category Disposal
8
Chemical waste
(Chemical used in production of
biologicals,
chemicals used in disinfection, as
insecticides, etc.)
Chemical treatment@ and
discharge into drains meeting
the norms notified under
these rules and solid disposal
in secured landfill
25
26. SEGREGATION OF WASTE
Colour coding and type of container for disposal of bio
medical wastes:
Colour
Coding
Type of container to
be used
Waste category number
Old
category
number
Treatment
options as per
schedule I
Yellow
Non-chlorinated plastic
bags
Category 1,2,5,6 1,2,3,6 Incineration
Red
Non-chlorinated plastic
bags/puncture proof
container for sharps
Category 3,4,7
(4-waste sharps) (in the
earlier Rules, soiled waste
are for red colour)
3,6,7
As per schedule I
(Rule 7)
Blue
Non-chlorinated plastic
bags container
Category 8 (chemical
waste)
4,7
As per schedule I
(Rule 7)
Black
Non-chlorinated plastic
bags
Municipal waste 5,9,10
Disposal in
Municipal dump
sites 26
27. LATEST RULE
GOVERNMENT OF INDIA
MINISTRY OF ENVIRONMENT, FOREST
AND CLIMATE CHANGE, 28th March, 2016
Biomedical wastes categories and their
segregation, collection, treatment,
processing and disposal options
27
31. OCCUPIER ,OPERATOR
Occupier- a person having administrative control over
the institution and the premises, generating
biomedical waste.
Operator of common biomedical waste treatment
facility- a person who owns or controls a common
Biomedical Waste Treatment facility (CBMWTF) for
collection, reception, storage, transport, treatment,
disposal or any other form of handling of biomedical
waste.
The occupier or operator of common biomedical
waste treatment facility shall be liable for action under
section 5 & section 15 of the Act, in case of any
violation.
31
32. DUTIES OF OCCUPIER
Take necessary steps to ensure BMW is handled
without adverse effect to human health &
environment
Make provision for central collection zone of
segregated waste within the premises acc. to color
code, provide safe, ventilated and secured location
for storage.
On site pretreatment of the laboratory waste,
microbiological waste, blood samples, blood bags
through disinfection or sterilization acc.to
WHO/NACO guideline then sent to final disposal
Phase out use of chlorinated plastic bags, gloves
and blood bags within 2 years from the date of
notification of these rules.-
32
33. CONTD…
Dispose solid waste other than BMW acc. to municipal waste law
Do not give treated biomedical waste with municipal waste
Provide training to all staff regarding handling of the BMW and
refresher training every year
Immunize all healthcare workers & others handling BMW
especially hepatitis B & Tetanus acc. to national immunization
guideline
Establish Bar-Code System for bags or containers containing
BMW to be sent out of the premises within 1 year of notification of
the rule
Provide adequate PPE
Ensure segregation of liquid chemical waste at source and
ensure pretreatment or neutralization prior to mixing with other
effluent generated from health care facilities.( Effluent drainage
system)
Conduct health check up at the time of induction and least once
in year 33
34. CONTD…
Monthly record on websites according to the biomedical waste
generated in terms of category and color coding .
Report major accidents including accidents caused by fire
hazards, blast during handling of BMW & remedial action taken
and relevant records in form-I to prescribed authority and also
along with annual report.
Make available annual report on its web site and all healthcare
facilities shall make own website within 2 years from the date of
notification of these rules.
Establish system to review & monitor the activities regarding
BMW through committee-meets every six month & record MOM
submitted along with annual report to prescribed authority.
Maintain all records of incineration /autoclaving for minimum 5
years.
Existing incineration meets standard for treatment & disposal of
BMW.(Dioxin and furans)
34
37. BIO-WASTE TREATMENT AND DISPOSAL-
OPERATOR RESPONSIBILITY
No occupier shall establish on site treatment & disposal
facility, if a service of common biomedical waste
treatment facility (CBMWTF) is available at a distance of
75 km.
In cases where BMW treatment facility is not available,
occupier shall set up requisite equipments like
incineration, autoclave, shredder prior to commencement
of its operation as per authorization given by prescribed
authority.
After treatment, the recyclable waste such as plastic &
glassware shall be given to such recyclers having valid
authorization or registration from respective prescribed
authority.
Also maintain records
37
38. STEPS TO MANAGE BIOMEDICAL WASTE
Segregation – at point of generation
Transportation – within hospital premises, and
from central storage to the point of final
treatment
Pretreatment – for microbiolgical waste, blood
bags, blood samples, vaccines
Storage
Final treatment
Documentation
38
39. SEGREGATION, TRANSPORT, STORAGE OF
WASTE
Segregation is carried out at the point of
generation to keep general waste from
becoming infectious
Segregation is according to color coding
system and BMW rule 2016
39
40. BIO-MEDICAL WASTE MANAGEMENT RULES, 2016
Category Type of waste Type of bag or
container to be
used
Treatment & disposal options
Yellow Human anatomical waste (Human
tissues, organs, body parts and fetus
below the viability period)
Yellow coloured non-
chlorinated plastic bags
Incineration or plasma pyrolysis or deep
burial* (only in rural & remote areas)
Animal anatomical waste (Experimental
animal carcasses, body parts, organs,
tissues, including the waste generated
from animals used in experiments or
testing in veterinary hospitals or colleges
or animal houses.)
Soiled waste (Items contaminated
with blood, body fluids like dressings,
plaster casts, cotton swabs and bags
containing residual or discarded blood
and blood components.)
Incineration or plasma pyrolysis or deep
burial*. Autoclaving or
microwaving/hydroclaving followed by
shredding or mutilation . Sent for energy
recovery
40
41. BIO-MEDICAL WASTE MANAGEMENT RULES, 2016
Category Type of waste Type of bag or
container to be
used
Treatment & disposal options
Yellow Expired or discarded medicines (Pharmaceutical
waste like antibiotics, cytotoxic drugs
including all items contaminated with cytotoxic
drugs along with glass or plastic ampoules, vials
etc.)
Yellow coloured non-
chlorinated plastic bags
or containers
Expired `cytotoxic drugs and items
contaminated with cytotoxic drugs to be
returned back to the manufacturer or
supplier for incineration at temperature
>1200°C or to common bio-medical
waste treatment facility or hazardous
waste treatment, storage and disposal
facility for incineration at >1200°C or
Encapsulation or Plasma Pyrolysis at
>1200°C.
All other discarded medicines shall be
either sent back to manufacturer or
disposed by incineration.
Chemical waste (Chemicals used in
production of biological and used or discarded
disinfectants.)
Yellow coloured non-
chlorinated plastic bags
Incineration or plasma pyrolysis or
encapsulation
Chemical liquid waste (Liquid waste generated
due to use of chemicals in production of
biological and used or discarded disinfectants,
Silver X-ray film developing liquid, discarded
Formalin, infected secretions, aspirated body
fluids, liquid from laboratories and floor
washings, cleaning, house-keeping and
disinfecting activities etc.)
Separate collection
system leading to
effluent treatment
system
After resource recovery, the chemical
liquid waste shall be pre-treated before
mixing with other wastewater. The
combined discharge shall conform to
the discharge norms given in Schedule-
III.
41
42. BIO-MEDICAL WASTE MANAGEMENT RULES, 2016
Category Type of waste Type of bag or container
to be used
Treatment & disposal
options
Yellow Discarded linen, mattresses, beddings
contaminated with blood or body fluid.
Yellow coloured non-chlorinated
plastic bags or suitable packing
material
Non- chlorinated chemical
disinfection followed by incineration
or Plazma Pyrolysis or for energy
recovery.
In absence of above facilities,
shredding or mutilation or
combination of sterilization and
shredding. Treated waste to be sent
for energy recovery or incineration or
Plazma Pyrolysis.
Microbiology, biotechnology &
other clinical laboratory waste
(Blood bags, Laboratory cultures,
stocks or specimens of
microorganisms, live or attenuated
vaccines, human and animal cell
cultures used in research, industrial
laboratories, production of
biological, residual toxins, dishes
and devices used for cultures.)
Autoclave safe plastic bags or
containers
Pre-treat to sterilize with
nonchlorinated chemicals on-site as
per National AIDS Control
Organisation or World Health
Organisation guidelines thereafter for
Incineration.
42
43. Category Type of waste Type of bag or container
to be used
Treatment & disposal options
Red Contaminated Waste
(Recyclable)
(a) Wastes generated
from disposable items
such as tubing,
bottles,
intravenous tubes and
sets, catheters, urine
bags, syringes
(without
needles and fixed
needle
syringes) and
vaccutainers with their
needles cut) and
gloves
Red coloured non-chlorinated
plastic bags or containers
Autoclaving or micro-waving/
hydroclaving followed by shredding or
mutilation or combination of
sterilization and shredding. Treated
waste to be sent to registered or
authorized recyclers or for energy
recovery or plastics to diesel or fuel oil
or for road making, whichever is
possible.
Plastic waste should not be sent to
landfill sites.
43
44. Category Type of waste Type of bag or container
to be used
Treatment & disposal options
White
(translucent)
Waste sharps including
metals
(Needles, syringes with
fixed needles, needles
from needle tip cutter or
burner, scalpels, blades,
or any other
contaminated sharp
object that may cause
puncture and cuts. This
includes both used,
discarded and
contaminated metal
sharps)
Puncture proof, leak proof,
tamper proof containers
Autoclaving or dry heat sterilization
followed by shredding or mutilation or
encapsulation in metal container or
cement concrete; final disposal to iron
foundries or sanitary landfill or
designated concrete waste sharp pit
44
45. Category Type of waste Type of bag or container
to be used
Treatment & disposal options
Blue Glassware
(Broken or discarded
and
contaminated glass
including medicine vials
and ampoules except
those contaminated with
cytotoxic wastes.)
Cardboard boxes with blue
coloured marking
Disinfection or autoclaving or
microwaving or hydroclaving & then
sent for recycling
Metallic body implants
45
58. ANNUAL TASKS
Training
Health check up-immunization
Submission of annual report form IV to
GPCB & displayed on web before 31th
January
Submission of accident report in form I &
MOM to GPCB with annual report.( nil report
as well)
58
60. PRE-TREATMENT & DECONTAMINATION
Autoclaving
Microwaving / Hydroclaving
Chemical disinfection (H2O2, Gluteraldehyde,
Phenol, Per acetic acid etc. )
Mutilation & shredding
60
61. DECONTAMINATION AND DISPOSAL OF SHARPS
After use, needles and syringes should be
locally destroyed / cut by a needle destroyer
and these should be collected in a rigid
container
Locate sharps disposal containers close to the
point of use e.g. in patient room, on the
medicine trolley and in the treatment room etc.
Dispose used sharps in a puncture resistant
white container.
Prevent overflow by sending sharps disposal
containers for autoclaving and shredding when
they are three quarters full.
61
62. FINAL DISPOSAL
The black bags and waste therein is
dispensed along with other municipal waste.
The bio-medical waste is collected and
disposed off.
All the waste generated in the department is
sent to common waste collection site after
decontamination.
62
63. BURNING ISSUES
Purchase of non chlorinated bags
New poster, new bags & their training regarding
segregation, transportation
Establish bar code system for bags
Establish effluent system for liquid waste
Formation of biomedical waste committee
Biochemistry & pathology lab should start autoclaving
121°C x 20 lbs x 60 min. of blood vaccuttee then discard
in RED bag
Blood bags to be autoclaved and discarded in yellow
bags.
To check sambremky treatment and disposal facilities for
standards of incineration & for treatment
63
64. SUMMARY
Bio medical waste categories are reduced
from 10 to 4.
Change in color coding system
64